Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 35, 2024 - Issue 1
Submit an article Journal homepage
0
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Estimating the healthcare burden of Prurigo Nodularis in England: a CPRD database study

Donia Bahloula Sanofi, Gentilly, FranceCorrespondence[email protected]
View further author information
,
Richard Hudsonb Sanofi, Reading, United KingdomView further author information
,
Orsolya Baloghb Sanofi, Reading, United KingdomView further author information
,
Elgan Mathiasc Human Data Sciences, Cardiff, United KingdomView further author information
,
Ben Heywoodc Human Data Sciences, Cardiff, United KingdomView further author information
,
Ellen Hubbuckc Human Data Sciences, Cardiff, United KingdomView further author information
,
Jules Tavia Sanofi, Gentilly, FranceView further author information
,
Onyi Diribeb Sanofi, Reading, United KingdomView further author information
,
Robert McDonaldb Sanofi, Reading, United KingdomView further author information
,
Simmi Wigginsb Sanofi, Reading, United KingdomView further author information
&
Anthony P. Bewleyd Barts Health NHS Trust and Queen Mary University, London, United KingdomView further author information
 show all
Article: 2367615 | Received 28 Nov 2023, Accepted 07 Jun 2024, Published online: 30 Jun 2024

References

  • British Association of Dermatologists. 2022. accessed 28 Oct 2022. Nodular Prurigo. https://www.bad.org.uk/pils/nodular-prurigo/.
  • Genetic and Rare Diseases Information Center. 2022. accessed 28 Oct 2022. Prurigo Nodularis. https://rarediseases.info.nih.gov/diseases/7480/prurigo-nodularis.
  • National Organization for Rare Disorders. 2022. Prurigo Nodularis. rarediseases.org (accessed 28 Oct 2022.
  • Ständer S, Ketz M, Kossack N, et al. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis. Acta Derm Venereol. 2020;100(18):1. doi: 10.2340/00015555-3655.
  • Morgan C, Thomas M, Ständer S, et al. Epidemiology of prurigo nodularis in England: a retrospective database analysis. Br J Dermatol. 2022;187(2):188–7. doi: 10.1111/bjd.21032.
  • Ryczek A, Reich A. Prevalence of Prurigo Nodularis in Poland. Acta Derm Venereol. 2020;100(10):adv00155. doi: 10.2340/00015555-3518.
  • Fostini AC, Girolomoni G, Tessari G. Prurigo nodularis: an update on etiopathogenesis and therapy. J Dermatolog Treat. 2013;24(6):458–462. doi: 10.3109/09546634.2013.814759.
  • Iking A, Grundmann S, Chatzigeorgakidis E, et al. Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients. J Eur Acad Dermatol Venereol. 2013;27(5):550–557. doi: 10.1111/j.1468-3083.2012.04481.x.
  • Huang AH, Canner JK, Williams KA, et al. Healthcare resource utilization and payer cost analysis of patients with prurigo nodularis. Br J Dermatol. 2020;183(1):182–184. doi: 10.1111/bjd.18925.
  • Whang KA, Kang S, Kwatra SG. Inpatient Burden of Prurigo Nodularis in the United States. Medicines (Basel). 2019;6(3):88. doi: 10.3390/medicines6030088.
  • Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi: 10.1093/ije/dyv098.
  • Hospital Episode Statistics. 2022. Health and Social Care Information Centre. accessed 28 Oct 2022. http://www.hscic.gov.uk/hes.
  • Office for National Statistics. 2022. Deaths Registration Data. accessed 28 Oct 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/birth sdeathsandmarriages/deaths.
  • Benson T. The history of the Read codes: the inaugural James Read memorial lecture 2011. Inform Prim Care. 2011;19(3):173–182. doi: 10.14236/jhi.v19i3.811.
  • Curtis L, Burns A. Unit Costs of Health and Social Care 2022. Canterbury: Personal Social Services Research Unit, University of Kent; 2022.
  • Hudson RDA, Ameen M, George SM, et al. A real-world data study on the healthcare resource use for uncontrolled moderate-to-severe atopic dermatitis in secondary care in the United Kingdom prior to the introduction of biologic treatment. Clinicoecon Outcomes Res. 2022;14:167–177. doi: 10.2147/CEOR.S333847.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.